To examine whether the elimination of SOX2/OCT4-overexpressing CSCs affects prostate cancer formation, nude mice were subcutaneously implanted with equal numbers of PC3 cells expressing SORE6-GFP or SORE6-TK, and then treated with GCV for 21 days. Here, SOX2 is linked to prostate carcinoma.